TECH FY 2015 Earnings Report — Bio-Techne Corporation Revenue & Financial Results | Market Cap Arena

Bio-Techne CorporationTECH

FY 2015 Earnings

Reported August 31, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2015	Prior Q	FY 2014	QoQ Change	YoY Change
Revenue	$452M	—	$358M	—	26.4%
Op. Income	$147M	—	$160M	—	-8.0%
Gross Margin	67.9%	—	70.3%	—	-2.3pp
Net Margin	23.8%	—	31.0%	—	-7.2pp
EPS (Diluted)	$0.72	—	$0.75	—	-4.0%
Free Cash Flow	$119M	—	$123M	—	-2.8%

Revenue Flow

Item	Amount
REVENUE	$452M
Cost of Revenue	$145M
GROSS PROFIT	$307M
R&D Expenses	$41M
Selling & Marketing	$0
General & Administrative	$119M
SG&A Expenses	$119M
Other Expenses	$0
Operating Expenses	$160M
Cost & Expenses	$305M
OPERATING INCOME	$147M
Interest Income	$634.0K
Interest Expense	$2M
Other Income/Expenses	$7M
INCOME BEFORE TAX	$154M
Income Tax Expense	$46M
Net Income from Continuing Ops	$108M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$108M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$108M
D&A	$37M
EBIT	$156M
EBITDA	$193M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$452M
Cost of Revenue	$145M
GROSS PROFIT	$307M
R&D Expenses	$41M
Selling & Marketing	$0
General & Administrative	$119M
SG&A Expenses	$119M
Other Expenses	$0
Operating Expenses	$160M
Cost & Expenses	$305M
OPERATING INCOME	$147M
Interest Income	$634.0K
Interest Expense	$2M
Other Income/Expenses	$7M
INCOME BEFORE TAX	$154M
Income Tax Expense	$46M
Net Income from Continuing Ops	$108M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$108M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$108M
D&A	$37M
EBIT	$156M
EBITDA	$193M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$108M
Depreciation & Amortization	$37M
Stock-Based Compensation	$6M
Deferred Income Tax	$1M
Other Non-Cash Items	-$1M
Change in Working Capital	-$11M
OPERATING CASH FLOW	$139M
Capital Expenditure	-$20M
Acquisitions (Net)	-$420M
Purchases of Investments	$0
Sales/Maturities of Investments	$13M
Other Investing Activities	$48.0K
NET CASH FROM INVESTING	-$426M
Net Debt Issuance	$68M
Common Stock Repurchased	$0
Common Dividends Paid	-$47M
Other Financing Activities	$10M
NET CASH FROM FINANCING	$31M
FREE CASH FLOW	$119M
Net Change in Cash	-$264M

Balance Sheet

Item	Amount
Cash & Equivalents	$55M
Short-Term Investments	$56M
Net Receivables	$70M
Inventory	$50M
Other Current Assets	$18M
TOTAL CURRENT ASSETS	$248M
PP&E (Net)	$130M
Goodwill	$391M
Intangible Assets	$293M
Long-Term Investments	-$12M
Tax Assets	$12M
Other Non-Current Assets	$2M
TOTAL NON-CURRENT ASSETS	$815M
TOTAL ASSETS	$1.1B
Account Payables	$13M
Short-Term Debt	$4M
Deferred Revenue	$3M
Other Current Liabilities	$7M
TOTAL CURRENT LIABILITIES	$40M
Long-Term Debt	$73M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$61M
Other Non-Current Liabilities	$42M
TOTAL NON-CURRENT LIABILITIES	$177M
TOTAL LIABILITIES	$216M
Common Stock	$371.0K
Additional Paid-In Capital	$163M
Retained Earnings	$714M
Treasury Stock	$0
Accum. Other Comp. Income	-$31M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$847M
Minority Interest	$0
TOTAL EQUITY	$847M
TOTAL LIABILITIES & EQUITY	$1.1B
Total Debt	$116M
Net Debt	$62M